Diversity and Inclusion

At EMA, we believe that diversity and inclusion (D&I) is vital to our success. We value the unique perspectives and backgrounds of our colleagues, and we are committed to fostering an inclusive workplace where everyone can thrive. This means our staff members must benefit from equal treatment and opportunities, irrespective of any ground such as sex, race, colour, ethnic or social origin, genetic features, language, religion or belief, political or any other opinion, membership of a national minority, property, birth, disability, age or sexual orientation, as stated in Article 1d of the Staff Regulations. Diversity and Inclusion (D&I) Working Group As part of our commitment to keep making EMA a diverse and inclusive workplace, the Diversity and Inclusion (D&I) Working Group has been established to: Help raise awareness of D&I issues, e.g. by supporting the organisation of training events, inviting guest speakers to raise awareness and change attitudes, and organising campaigns and events to promote best practices. Cooperate with other EU institutions and bodies, and sharing information and good practices related to D&I topics. Mobilise senior management and staff by offering them the roles of 'D&I ambassador' and 'D&I ally'. Extend collaboration to groups of staff who are keen to become involved in D&I activities. Support the development of EMA's D&I policy within the future 'HR strategy' that is currently being developed. The Diversity and Inclusion Working Group is formed by colleagues from different areas of The Agency and different levels of seniority and managerial responsibilities. The Diversity and Inclusion Working Group on annual basis develops, implements and reports on an action plans with specific goals and measures to improve D&I aspects within the Agency.

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.